Medivis Secures FDA Clearance for Breakthrough Augmented Reality Surgical System
FREMONT, CA: The New York city based medical technology firm, Medivis has come up with SurgicalAR allowing operators to have superior understanding, confidence, efficiency, and precision for every patient. This groundbreaking augmented reality surgical planning toolkit, SurgicalAR has won clearance for clinical use in the operating room by the Food and Drug Administration. Launched SurgicalAR earlier this year, the company will commence the immediate commercialization of the platform in the U.S.
The platform is a visualization tool that guides surgical navigation, which Medivis claims can reduce complications and enhance patient outcomes, at the same time lowering surgical costs. A bulk of medical procedures are performed relatively blindly, with surgeons having to reconstruct slices of 2D imaging data in the mind’s eye to make it actionable. The enterprise SurgicalAR integrates the latest advancements in augmented reality, artificial intelligence and computer vision to advance surgical visualization, to overcome such challenges.
Medivis rolls out advancements in holographic visualization and navigation to fundamentally advance surgical intervention and revolutionize how surgeons safely operate on their patients that will ultimately improve surgical precision and safety.
In addition to its hardware partnership, the company has launched a toolkit for educational raining in augmented reality, the AnatomyX platform. The platform for medical training is available on HoloLens and Magic Leap’s devices and is already in use at West Coast University. Another upstart of Medivis Vicarious Surgical is combining visualization tools with robotics to facilitate remote surgeries that could happen across the globe.
The medical technology industry is a significant part of the healthcare sector that includes medical devices which simplify the diagnosis and treatment, and prevention of diseases. MedTech companies invest heavily in improving technologies and developing breakthroughs that deliver for patients and other healthcare stakeholders.